Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia in Needling with Lidocaine (ANELI)
2023-505131-13-01Phase 4Suspended
- Sponsor
- Hospital del Mar
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of CU-30101 and tetracaine + oxybuprocaine in Glaucoma (2 arms), sponsored by Hospital del Mar. Primary endpoints: Pain during needling procedure and Surgeon comfort/degree of patient cooperation. Started Dec 2023; status: suspended.
02
Drugs
CU-30101tetracaine + oxybuprocaine
03
Conditions
Glaucoma
Beyond the preview
Go deeper on 2023-505131-13-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505131-13-01.